Shortly after the opening bell Wednesday, we will be buying 75 shares of GE HealthCare Technologies , at roughly $66.17 apiece. Following the trade, Jim Cramer's Charitable Trust will own 1,245 shares of GEHC, increasing its weighting in the portfolio to 3.06% from 2.88%. With U.S. equities down in premarket trading Wednesday and the S & P 500 Short Range Oscillator still highly oversold, at minus 5.36%, we are putting money to work on the expectation the market could soon bounce.
The company also told a compelling story around expected margin expansion due to a raft of new product introductions, including those integrated with artificial intelligence that command a much higher price point relative to legacy offerings. We also think the market is still underappreciating how well the company is positioned to benefit from the rollout of new Alzheimer's treatments, which require brain scans provided by GE HealthCare's technology.